Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.
Feedback announces launch of CareLocker to enhance its Bleepa technology
· Revolutionary GDPR compliant patient-centric cloud architecture to underly the Bleepa platform
· Increases the opportunities for Bleepa adoption across multiple care settings
· Proprietary technology enables an easy route to creation and mobilisation of individual healthcare records
· The perfect infrastructure to support roll-out of regional care delivery programmes such as the Community Diagnostic Hub initiative
London, 09 September 2021: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist clinical communication company, announces that it is launching a new Bleepa product - CareLocker.
CareLocker is a new proprietary and patient-centric cloud architecture that supports Bleepa's functionality whilst simultaneously creating patient specific records of care episodes. CareLocker will enable Bleepa to deliver care across provider settings in a secure and scalable way.
Bleepa provides practitioners with mobile access to patient data, including medical images, allowing secure communication and on-the-go decision making. As a clinical tool Bleepa integrates with multiple hospital systems and centralises relevant clinical data around specific patient episodes, from which clinical teams can accelerate decision making capabilities through the platform. This data includes lab results, structured reports, ECGs and most importantly medical images, which are uniquely displayed through Bleepa's regulated DICOM viewer. CareLocker provides a patient-centric way of storing data and because the patient record is de-centralised, they can be accessed by any care setting through open Application Programming Interfaces (APIs) such as FHIR.
CareLocker provides patient-centric cloud data stores: containers that store medical data at an individual patient level. With this proprietary architecture, patient data can be secured at the individual level, with access control even to subsets of a patient's data. CareLocker offers opportunities for improved storage optimisation making it more cost effective than traditional data storage architectures. Most importantly, CareLockers can be built on a patient-by-patient basis, allowing organisations to transition to a cloud architecture as patients enter care pathways rather than having to undertake the mass data migrations usually associated with cloud transitions.
Where Bleepa is installed in multiple regional provider settings, the migration of data into a patient specific record can happen at a regional level, breaking down provider siloes. One topical area of application is in facilitating the £10bn Community Diagnostic Hub (CDH) initiative launched by NHS England to help address the elective care backlog by bringing diagnostic services out of hospital settings and closer to patients. CDHs will typically complete a suite of diagnostic tests, the results of which must all be made available to the clinical teams, both in the primary and secondary care setting, creating a patient pathway that bridges multiple care settings. This end-to-end patient-specific pathway requires a digital infrastructure designed to both connect clinical teams and manage the associated data flow. Bleepa and CareLocker in combination provide this, with Bleepa as an application and user interface and CareLocker as the underlying data architecture.
Dr Tom Oakley, CEO of Feedback, said: "CareLocker is the latest development in the Bleepa story and has the potential to be a significant catalyst to multiple commercial opportunities. We have been working on this concept for many months in order to position Bleepa for multi-site adoption and to meet the emerging needs of the CDH initiative to address the elective care backlog. Currently patient data is siloed within disparate hospital systems and within individual clinical settings, this makes delivering regional care extremely difficult. In some cases it can take hours to transfer imaging between two hospitals and this ultimately effects patient care. CareLocker is a solution that can transform care delivery at an individual hospital, regional or even national level. Patient-centric cloud storage is the future of medical data and a natural result of patient centred care. We believe Carelocker provides the platform our customers need and is right at the cutting edge of communication technology. With this platform in place we will be accelerating the opportunities for adoption across multiple settings."
Further information on CareLocker can be found on the Company's website www.fbkmed.com
Tom Oakley, CEO
Lindsay Melvin, CFO
+44 (0)1954 718072
Panmure Gordon (UK) Limited (NOMAD and Broker)
Emma Earl/Freddy Crossley (Corporate Finance)
Rupert Dearden (Corporate Broking)
+44 (0)20 7886 2500
Walbrook PR Ltd
Tel: 020 7933 8780 or firstname.lastname@example.org
Paul McManus/Nick Rome/Nicholas Johnson
07980 541 893 or 07748 325 236 or 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a pioneer of regulated clinical communication products. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care providers. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of clinical review.